forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Receptor Agonist Market Analysis GLP-1 Receptor Agonist Market Size

Long-Acting GLP-1 is the major leading segment of GLP-1 Receptor Agonist market in terms of Drug Type

While obesity was once widely viewed as a matter of personal responsibility and failed weight management, the Swiss healthcare system now treats it as a condition requiring long-term management, similar to hypertension and diabetes

concluded that tirzepatide was found to be effective in improving cardiac dysfunction and increasing survival rates in mice that were treated with LPS

Our clients have experienced impressive results, with many reporting increased muscle strength, better endurance, and more effective weight management